Related references
Note: Only part of the references are listed.23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
Thomas Chandler et al.
MICROORGANISMS (2022)
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic
Hugh Adler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Dynamics of Pneumococcal Carriage in Adults: A New Look at an Old Paradigm
Sonia T. Almeida et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Experimental Human Challenge Defines Distinct Pneumococcal Kinetic Profiles and Mucosal Responses between Colonized and Non-Colonized Adults
Elissavet Nikolaou et al.
MBIO (2021)
Effectiveness of the 7-and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media
Ron Dagan et al.
CLINICAL INFECTIOUS DISEASES (2021)
Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
Heather L. Sings et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018
Zahin Amin-Chowdhury et al.
CLINICAL INFECTIOUS DISEASES (2020)
Upper respiratory tract colonization withStreptococcus pneumoniaein adults
Adriano Arguedas et al.
EXPERT REVIEW OF VACCINES (2020)
Pneumococcal colonisation is an asymptomatic event in healthy adults using an experimental human colonisation model
Ashleigh Trimble et al.
PLOS ONE (2020)
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease
Jennifer N. Luck et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands
Bradford D. Gessner et al.
VACCINE (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density
E. L. German et al.
VACCINE (2019)
A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands
Bradford D. Gessner et al.
VACCINE (2019)
Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader
Natalie Groves et al.
GENES (2019)
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
Almea Matanock et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
Heather L. Sings et al.
CLINICAL INFECTIOUS DISEASES (2019)
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study
Anna M. M. van Deursen et al.
CLINICAL INFECTIOUS DISEASES (2018)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Experimental infection of human volunteers
Meta Roestenberg et al.
LANCET INFECTIOUS DISEASES (2018)
Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci
Taj Azarian et al.
PLOS PATHOGENS (2018)
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Gerhard Falkenhorst et al.
PLOS ONE (2017)
Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies
Eun Hwa Choi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage
Shaun H. Pennington et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis
Hannah Kraicer-Melamed et al.
VACCINE (2016)
Carriage of Streptococcus pneumoniae in asymptomatic, community-dwelling elderly in the Netherlands
Anna M. M. van Deursen et al.
VACCINE (2016)
Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
Wen-qi Diao et al.
VACCINE (2016)
First Human Challenge Testing of a Pneumococcal Vaccine Double-Blind Randomized Controlled Trial
Andrea M. Collins et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Density and duration of experimental human pneumococcal carriage
J. F. Gritzfeld et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
PNEUMOCOCCAL CONJUGATE VACCINE REDUCES RATE, DENSITY AND DURATION OF EXPERIMENTAL HUMAN PNEUMOCOCCAL COLONISATION: FIRST HUMAN CHALLENGE TESTING OF A PNEUMOCOCCAL VACCINE
A. M. Collins et al.
THORAX (2014)
Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults
Daniela M. Ferreira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
Ron Dagan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia
Susanne M. Huijts et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
An-Wen Chan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Experimental Human Pneumococcal Carriage
Jenna F. Gritzfeld et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Human Nasal Challenge with Streptococcus pneumoniae Is Immunising in the Absence of Carriage
Adam K. A. Wright et al.
PLOS PATHOGENS (2012)
Experimental human pneumococcal carriage models for vaccine research
Daniela M. Ferreira et al.
TRENDS IN MICROBIOLOGY (2011)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting
M Hussain et al.
EPIDEMIOLOGY AND INFECTION (2005)
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults:: A longitudinal household study
D Goldblatt et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Share Paper
